FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Aurobindo Pharma Gabapentin Capsules Recall

Gabapentin Capsules, USP 300 mg, 100-count bottles, Rx only, Manufactured for: Northsta…

Aurobindo Pharma USA Inc · Dayton, NJ

Risk level
Class II
Reported by FDA
Jan 14, 2015
Recall ID
D-0330-2015
Check your lot numberHow we source this data

Summary

Aurobindo Pharma recalled Gabapentin Capsules starting Oct 17, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0330-2015 on Jan 14, 2015. Reason: Failed Tablet/Capsule Specifications: Complaints of empty capsules received. Status: Terminated.

Why it was recalled

Failed Tablet/Capsule Specifications: Complaints of empty capsules received.

Product description

Gabapentin Capsules, USP 300 mg, 100-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141; Manufactured by: Aurobindo Pharma Limited, Unit-VII (SEZ), Mahaboob Nagar (Dt), AP-509302, INDIA, NDC 16714-662-01, UPC 3 16714-662-01 5.

Lot numbers, UPCs & expiration codes

Lot #: GESB14011-A, Exp 12/15

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0330-2015
Classification
Class II
Status
Terminated
Recall initiated
Oct 17, 2014
FDA report date
Jan 14, 2015
Quantity
24,816 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Aurobindo Pharma USA Inc

Original FDA data

Every field from FDA enforcement report D-0330-2015, exactly as published.

Show all FDA fields
City
Dayton
State
NJ
Status
Terminated
Country
United States
Event ID
69807
Address
6 Wheeling Road
Code information
Lot #: GESB14011-A, Exp 12/15
Postal code
08810
Report date
Jan 14, 2015
Product type
Drugs
Recall number
D-0330-2015
Classification
Class II
Recalling firm
Aurobindo Pharma USA Inc
Product quantity
24,816 bottles
Termination date
May 23, 2016
Reason for recall
Failed Tablet/Capsule Specifications: Complaints of empty capsules received.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Gabapentin Capsules, USP 300 mg, 100-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141; Manufactured by: Aurobindo Pharma Limited, Unit-VII (SEZ), Mahaboob Nagar (Dt), AP-509302, INDIA, NDC 16714-662-01, UPC 3 16714-662-01 5.
Distribution pattern
Nationwide
Recall initiation date
Oct 17, 2014
Initial firm notification
Letter
Center classification date
Jan 6, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0330-2015, published Jan 14, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls